These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 448068)

  • 1. Identity of C3- and C5-receptors on lymphoid cells.
    Landen B; Dierich MP
    J Immunol; 1979 Mar; 122(3):1015-7. PubMed ID: 448068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement receptors on Raji cells. The presence of a new type of C3 receptor.
    Okuda T; Tachibana T
    Immunology; 1980 Sep; 41(1):159-66. PubMed ID: 7429548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3-mediated cytoadherence. II. Dependence of cell attachment on similar topographic distribution of the receptors (for C3) and the ligands (C3/C3b).
    Landen B; Strunkheide K; Dierich MP
    J Immunol; 1978 Dec; 121(6):2539-41. PubMed ID: 102696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative and quantitative assessment of C3-receptor reactivities on lymphoid and phagocytic cells.
    Schmitt M; Mussel HH; Dierich MP
    J Immunol; 1981 May; 126(5):2042-7. PubMed ID: 7217681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
    Kitamura H; Tsuboi M; Nagaki K
    Immunology; 1986 Jul; 58(3):459-65. PubMed ID: 3733147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils.
    Gerdes J; Klatt U; Stein H
    Immunology; 1980 Jan; 39(1):75-84. PubMed ID: 6991397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3- and T-cell-dependent adjuvant activity of in vivo formed immune complexes.
    Van den Berg CW; Hazenberg MA; Hofhuis FM; Van Rooyen SM; Van Dijk H
    Immunology; 1991 Jul; 73(3):264-70. PubMed ID: 1879875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C3 receptors on lymphoid cells: isolation of active membrane fragments and solubilization of receptor complexes.
    Dierich MP; Reisfeld RA
    J Immunol; 1975 Jun; 114(6):1676-82. PubMed ID: 1055171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Components of human complement system. Testing and isolation of C3 and C5].
    Kosiak AV; Shukun SA; Poddubkova TN; Chikh VP; Surovtsev VI
    Biokhimiia; 1990 Feb; 55(2):276-84. PubMed ID: 2340315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by C3 fragments of C3-dependent rosette formation and antigen-induced lymphocyte transformation.
    Pepys MB; Butterworth AE
    Clin Exp Immunol; 1974 Oct; 18(2):273-82. PubMed ID: 4619599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of C3b receptors on human lymphocytes, phagocytes, erythrocytes and renal glomerulus cells by monoclonal antibodies.
    Dierich MP; Mussel HH; Scheiner O; Ehlen T; Burger R; Peters H; Schmitt M; Trepke S; Zimmer G
    Immunology; 1982 Jan; 45(1):85-96. PubMed ID: 7056569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement receptor analogous factors in human serum: I. Isolation of a molecule inhibitory for complement dependent rosette formation, its identification as alpha 1-antitrypsin and its functional characterization.
    Dierich MP; Landen B; Schmitt M
    Immunobiology; 1979 Aug; 156(1-2):153-67. PubMed ID: 317275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro complement activation by rabbit lymphocytes and thymocytes in autologous serum.
    Wilson AB; Lachmann PJ; Coombs RR
    Immunology; 1979 May; 37(1):25-34. PubMed ID: 112041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the activity of the classical complement pathway C3 convertase by surface-bound C3 or C5.
    Strunk RC; Giclas PC
    J Immunol; 1980 Feb; 124(2):520-6. PubMed ID: 7356706
    [No Abstract]   [Full Text] [Related]  

  • 15. Study on C3-like factor in the serum of a C3-deficient subject.
    Kitamura H; Nishimukai H; Sano Y; Nagaki K
    Immunology; 1984 Feb; 51(2):239-45. PubMed ID: 6693133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune adherence in renal glomeruli. Complement receptor sites on glomerular capillary epithelial cells.
    Burkholder PM; Oberley TD; Barber TA; Beacom A; Koehler C
    Am J Pathol; 1977 Mar; 86(3):635-54. PubMed ID: 842614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated guinea-pig C3 and the immune adherence receptor (a complement receptor) on cell membranes.
    Okada H; Okada N
    Immunology; 1975 Jun; 28(6):1165-71. PubMed ID: 1169221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C3 and C5 compete for the same binding site on complement receptor cells.
    Dierich MP; Landen B
    Adv Exp Med Biol; 1979; 114():189-90. PubMed ID: 463639
    [No Abstract]   [Full Text] [Related]  

  • 19. Shedding and reappearance of Fc, C3 and SRBC receptors on peripheral lymphocytes from normal donors and chronic lymphatic leukaemia (CLL) patients.
    Sármay G; István L; Gergely J
    Immunology; 1978 Feb; 34(2):315-21. PubMed ID: 627410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family.
    Low PJ; Ai R; Ogata RT
    J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.